scispace - formally typeset
R

Rossella Parini

Researcher at University of Milano-Bicocca

Publications -  201
Citations -  7423

Rossella Parini is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Enzyme replacement therapy & Fabry disease. The author has an hindex of 43, co-authored 197 publications receiving 6452 citations. Previous affiliations of Rossella Parini include University of Padua & University of Milan.

Papers
More filters
Journal ArticleDOI

The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS)

TL;DR: There is no evidence at present for predicting disease severity in patients with Hunter syndrome based on changes in growth characteristics, and Logistic regression modelling found that increased BMI was associated with the presence of cognitive impairment.
Journal ArticleDOI

First manifestation of citrullinemia type I as differential diagnosis to postpartum psychosis in the puerperal period.

TL;DR: A severe hyperammonemic coma is found during the postpartum period in three women who were all shown to suffer from a yet undiagnosed inborn error of amino acid metabolism, citrullinemia type I, and the inclusion of metabolic studies for all acute neurological symptoms in the puerperal period is suggested.
Journal ArticleDOI

Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area.

TL;DR: The data confirm the extreme genetic heterogeneity of this disease, thus precluding a strategy of mutation finding based on screening of recurrent common mutations, and identifies seven novel mutations from a collection of 18 independent alleles from the Mediterranean area.
Journal ArticleDOI

Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.

TL;DR: The main clinical and biochemical features of patients suffering from GM3 synthase or GM2/GD2/GA2 synthase deficiency, compared with the phenotypes described in mice that are null for single or multiple glycosyltransferase genes, provide suggestions to improve the recognition of novel mutations and potentially related disorders.